# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 8: Amendment of Schedule 1 (further provisions for classification of medicinal products)

Extent: E+W+S+N.I.

In Schedule 1—
(a) in paragraph 1—
(i) in sub-paragraph (b), insert “UK” before “marketing authorisation”;
(ii) in sub-paragraphs (e)(i), (f)(i) and (g)(i), for “marketing authorisation” substitute “UK marketing authorisation, EU marketing authorisation, Article 126a authorisation or parallel import licence”; and
(b) in paragraph 4, for “marketing authorisation” substitute “UK marketing authorisation, EU marketing authorisation, Article 126a authorisation, parallel import licence”.

---
Source: https://www.legislation.gov.uk/uksi/2019/775/regulation/8 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-8
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.